These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 21071777

  • 1. Central nervous system involvement in a rare genetic iron overload disorder.
    Bethlehem C, van Harten B, Hoogendoorn M.
    Neth J Med; 2010 Oct; 68(10):316-8. PubMed ID: 21071777
    [Abstract] [Full Text] [Related]

  • 2. Novel ceruloplasmin mutation causing aceruloplasminemia with hepatic iron overload and diabetes without neurological symptoms.
    Rusticeanu M, Zimmer V, Schleithoff L, Wonney K, Viera J, Zimmer A, Hübschen U, Bohle RM, Grünhage F, Lammert F.
    Clin Genet; 2014 Mar; 85(3):300-1. PubMed ID: 23557349
    [No Abstract] [Full Text] [Related]

  • 3. Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia?
    Pelucchi S, Pelloni I, Arosio C, Mariani R, Piperno A.
    Blood Cells Mol Dis; 2016 Mar; 57():112-4. PubMed ID: 26777753
    [No Abstract] [Full Text] [Related]

  • 4. Movement disorders and brain iron overload in a new subtype of aceruloplasminemia.
    Melgari JM, Marano M, Quattrocchi CC, Piperno A, Arosio C, Frontali M, Nuovo S, Siotto M, Salomone G, Altavilla R, di Biase L, Scrascia F, Squitti R, Vernieri F.
    Parkinsonism Relat Disord; 2015 Jun; 21(6):658-60. PubMed ID: 25864092
    [No Abstract] [Full Text] [Related]

  • 5. [Aceruloplasminemia, a rare condition not to be overlooked].
    Lobbes H, Reynaud Q, Mainbourg S, Lega JC, Durieu I, Durupt S.
    Rev Med Interne; 2020 Nov; 41(11):769-775. PubMed ID: 32682623
    [Abstract] [Full Text] [Related]

  • 6. Identification and in silico characterization of a novel compound heterozygosity associated with hereditary aceruloplasminemia.
    Hofmann WP, Welsch C, Takahashi Y, Miyajima H, Mihm U, Krick C, Zeuzem S, Sarrazin C.
    Scand J Gastroenterol; 2007 Sep; 42(9):1088-94. PubMed ID: 17710675
    [Abstract] [Full Text] [Related]

  • 7. Hepatic iron overload associated with a decreased serum ceruloplasmin level in a novel clinical type of aceruloplasminemia.
    Kono S, Suzuki H, Takahashi K, Takahashi Y, Shirakawa K, Murakawa Y, Yamaguchi S, Miyajima H.
    Gastroenterology; 2006 Jul; 131(1):240-5. PubMed ID: 16831606
    [Abstract] [Full Text] [Related]

  • 8. Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate.
    Kuhn J, Bewermeyer H, Miyajima H, Takahashi Y, Kuhn KF, Hoogenraad TU.
    Brain Dev; 2007 Aug; 29(7):450-3. PubMed ID: 17307325
    [Abstract] [Full Text] [Related]

  • 9. Aceruloplasminaemia: a family with a novel mutation and long-term therapy with deferasirox.
    Lindner U, Schuppan D, Schleithoff L, Habeck JO, Grodde T, Kirchhof K, Stoelzel U.
    Horm Metab Res; 2015 Apr; 47(4):303-8. PubMed ID: 25089372
    [Abstract] [Full Text] [Related]

  • 10. Aceruloplasminaemia: a rare but important cause of iron overload.
    Doyle A, Rusli F, Bhathal P.
    BMJ Case Rep; 2015 May 14; 2015():. PubMed ID: 25976187
    [Abstract] [Full Text] [Related]

  • 11. Aceruloplasminemia: an update.
    Kono S.
    Int Rev Neurobiol; 2013 May 14; 110():125-51. PubMed ID: 24209437
    [Abstract] [Full Text] [Related]

  • 12. [Hereditary iron overload].
    Brissot P, Bardou-Jacquet E, Latournerie M, Ropert-Bouchet M, Island ML, Loréal O, Jouanolle AM.
    Pathol Biol (Paris); 2010 Oct 14; 58(5):316-23. PubMed ID: 19942367
    [Abstract] [Full Text] [Related]

  • 13. Aceruloplasminaemia with progressive atrophy without brain iron overload: treatment with oral chelation.
    Skidmore FM, Drago V, Foster P, Schmalfuss IM, Heilman KM, Streiff RR.
    J Neurol Neurosurg Psychiatry; 2008 Apr 14; 79(4):467-70. PubMed ID: 17911185
    [Abstract] [Full Text] [Related]

  • 14. Diagnosing aceruloplasminemia: navigating through red herrings.
    Kharel Z, Kharel H, Phatak PD.
    Ann Hematol; 2024 Jun 14; 103(6):2173-2176. PubMed ID: 38637332
    [Abstract] [Full Text] [Related]

  • 15. Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders.
    Kaneko Y, Miyajima H, Piperno A, Tomosugi N, Hayashi H, Morotomi N, Tsuchida K, Ikeda T, Ishikawa A, Ota Y, Wakusawa S, Yoshioka K, Kono S, Pelucchi S, Hattori A, Tatsumi Y, Okada T, Yamagishi M.
    J Gastroenterol; 2010 Nov 14; 45(11):1163-71. PubMed ID: 20533066
    [Abstract] [Full Text] [Related]

  • 16. Aceruloplasminemia in an asymptomatic patient with a new mutation. Diagnosis and family genetic analysis.
    Pérez-Aguilar F, Burguera JA, Benlloch S, Berenguer M, Rayón JM.
    J Hepatol; 2005 Jun 14; 42(6):947-9. PubMed ID: 15885371
    [Abstract] [Full Text] [Related]

  • 17. Neurodegeneration With Brain Iron Accumulation: A Novel Mutation in the Ceruloplasmin Gene.
    Stelten BML, van Ommen W, Keizer K.
    JAMA Neurol; 2019 Feb 01; 76(2):229-230. PubMed ID: 30383083
    [No Abstract] [Full Text] [Related]

  • 18. Ceruloplasmin deficiency does not induce macrophagic iron overload: lessons from a new rat model of hereditary aceruloplasminemia.
    Kenawi M, Rouger E, Island ML, Leroyer P, Robin F, Rémy S, Tesson L, Anegon I, Nay K, Derbré F, Brissot P, Ropert M, Cavey T, Loréal O.
    FASEB J; 2019 Dec 01; 33(12):13492-13502. PubMed ID: 31560858
    [Abstract] [Full Text] [Related]

  • 19. H63D homozygotes with hyperferritinaemia: Is this genotype, the primary cause of iron overload?
    de Diego C, Opazo S, Murga MJ, Martínez-Castro P.
    Eur J Haematol; 2007 Jan 01; 78(1):66-71. PubMed ID: 17042772
    [Abstract] [Full Text] [Related]

  • 20. Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability.
    Fasano A, Colosimo C, Miyajima H, Tonali PA, Re TJ, Bentivoglio AR.
    Mov Disord; 2008 Apr 15; 23(5):751-5. PubMed ID: 18200628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.